Use of the small pelvic field instead of the classic whole pelvic field in postoperative radiotherapy for cervical cancer: Reduction of adverse events

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 1, 2004, Pages 258-264

  Ohara, Kiyoshi ^a   Tsunoda, Hajime ^a   Satoh, Toyomi ^a   Oki, Akinori ^a   Sugahara, Shinji ^a   Yoshikawa, Hiroyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Pelvic control; Radiation toxicity; Target volume; Treated volume

Indexed keywords

HEMOPOIETIC SYSTEMS; LEUKOPENIA;

CELLS; CHEMOTHERAPY; DISEASES; SURGERY; TOXICITY; TUMORS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; DIARRHEA; FEMALE; HUMAN; ILEUS; LEUKOPENIA; LYMPHEDEMA; NAUSEA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER;

ADULT; AGED; DIARRHEA; FEMALE; HUMANS; LEUKOPENIA; LYMPHATIC METASTASIS; MIDDLE AGED; NAUSEA; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 4444239001     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.02.023     Document Type: Article

References (19)

1. Delgado G., Bundy B., Zaino R., et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix A Gynecologic Oncology Group study. Gynecol Oncol. 38:1990;352-357
2. Stitt J.A. Use of postoperative irradiation for carcinoma of the cervix. Semin Radiat Oncol. 4:1994;41-45
3. Lai C.H., Hong J.H., Hsueh S., et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastasis An analysis of 891 cases. Cancer. 85:1999;1537-1546
4. Sedlis A., Bundy B.N., Rotman M.Z., et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy A Gynecologic Oncology Group Study. Gynecol Oncol. 73:1999;177-183
5. Koh W.J., Panwala K., Greer B. Adjuvant therapy for high-risk, early stage cervical cancer. Semin Radiat Oncol. 10:2000;51-60
6. Barter J.F., Soong S.J., Shingleton H.M., et al. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol. 32:1989;292-296
7. Magrina J.F. Complications of irradiation and radical surgery for gynecologic malignancies. Obstet Gynecol Surv. 48:1993;571-575
8. Landoni F., Maneo A., Colombo A., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 350:1997;535-540
9. Ohara K., Tsunoda H., Nishida M., et al. Use of small pelvic field instead of whole pelvic field in postoperative radiotherapy for node-negative, high-risk stages I and II cervical squamous cell carcinoma. Int J Gynecol Cancer. 13:2003;170-176
10. Common Toxicity Criteria, version 2.0, June 1, 1999. Available at: http://ctep.info.nih.gov/reporting/ctc.html. Accessed July 2003
11. ICRU (International Commission on Radiation Units and Measurements) Report 50. Prescribing, recording and reporting photon beam therapy. Bethesda, MD: ICRU; 1993
12. Portelance L., Chao K.S., Grigsby P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 51:2001;261-266
13. Mundt A.J., Lujan A.E., Rotmensch J., et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 52:2002;1330-1337
14. Covens A., Rosen B., Gibbons A., et al. Difference in the morbidity of radical hysterectomy between gynecological oncologists. Gynecol Oncol. 51:1993;39-45
15. Montz F.J., Holschneider C.H., Solh S., et al. Small bowel obstruction following radical hysterectomy Risk factors, incidence, and operative findings. Gynecol Oncol. 53:1994;114-120
16. Ralph G., Tamussino K., Lichtenegger W. Urological complications after radical hysterectomy with or without radiotherapy for cervical cancer. Arch Gynecol Obstet. 248:1990;61-65
17. Chatani M., Nose T., Masaki N., et al. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications. Strahlenther Onkol. 174:1998;504-509
18. Eifel P.J., Levenback C., Wharton J.T., et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 32:1995;1289-1300
19. Consensus Statement: National Institutes of Health Consensus Development Conference Statement on Cervical Cancer. Gynecol Oncol 1997;66:351-361